Background-There is evidence that measles virus infection in early life may predispose to Crohn's disease.
Aims-To examine using serological methods a potential association between measles virus infection in early life and predisposition to Crohn's disease. Subjects-Forty five patients with Crohn's disease and forty five healthy controls were studied prospectively. Methods-Clinical data were recorded and serum was analysed for measles virus, cytomegalovirus (CMV), adenovirus and herpes simplex virus (HSV) antibody titres by a complement fixation test (CFT), and for measles virus IgM by enzyme linked immunosorbent assay (ELISA). Results-Reciprocal CFT titres for measles virus were lower in patients with Crohn's disease compared with controls (p<005); there was no significant difference in titres for other viruses. None ofthe subjects studied had a level of measles virus IgM suggestive of acute infection, and there was no significant difference in measles virus IgM levels between patients and controls. The measles virus CFT titres and IgM levels in the patients with Crohn's disease did not CFT results for measles virus varied from less than 1 in 10 (<1:10) to greater than or equal to 1 in 320 (.1:320). 20 20 Interquartile range were the same for patients and controls for each of the three viruses, and overall values were not significantly different between patients with Crohn's disease and controls (table 1) .
Measles virus IgM levels were not considered diagnostic of recent or acute measles virus infection in any of the patients with Crohn's disease or controls. However, there was a trend towards lower values in patients with Crohn's disease compared with controls. The mean optical density (OD) value in patients with Crohn's disease was 0-128 and was 0-219 in controls (NS) (an OD value of >1 1 is suggestive of recent infection). Correlation between measles virus CFT titres and IgM levels for all patients and controls combined was poor (Spearman rank coefficient 0-04, NS). For patients with Crohn's disease, measles virus CFT and IgM antibody titres were analysed according to drug therapy; patients were divided into two groups (group 1, 5-ASA derivatives alone or no medication, n=27; group 2, any immunosuppressive agents with or without 5-ASA derivatives, n= 18). For CFT titres, there was no significant difference between groups. However, IgM levels were higher in group 2 were 0-39, 017, and 0-66 compared with the mean of 0128 for the Crohn's disease group overall.
The paired serum samples from two local cases of acute measles virus infection which had previously shown a fourfold increase in measles virus CFT titre again showed a fourfold increase with our current assay. Measles virus IgM analysis gave a positive result in one case and an equivocal result in the other (OD values 1.17 and 0-80, respectively).
Discussion
Raised antibody titres to measles virus might be expected in Crohn's disease if there is a causative association between the two diseases, but our study, like a previous study of intrafamilial cases of Crohn's disease,8 has failed to find any such association. On the contrary, there was reduced antibody by CFT and a trend towards reduced IgM activity by ELISA in patients with Crohn's disease compared with controls. The inverse association between Crohn's disease and measles virus antibody titres by CFT was not found for other viruses. It is possible that this latter discrepancy was a chance finding as the range of CFT titres for the other viruses tested was low both in patients with Crohn's disease and control groups compared with that for measles virus.
The value of CFT titres in diagnosing measles virus infection is limited; a fourfold increase in tlitres between acute and convalescent serum is considered essential for confirmation of clinically suspected acute infection, and absolute values may not be helpful. This limitation may apply to our study, but, given the long delay that would separate acute measles virus infection and subsequent Crohn's disease, it would be difficult to obtain meaningful paired samples. It is worth noting that the CFT titres in late SSPE may rise to extremely high levels (characteristically >1:1000), "1 12 and no such levels were encountered in any of our patients with Crohn's disease. 5 16 Our concern that CFT titres (measuring predominantly IgG antibody) might not accurately reflect current or reactivated infection led us to perform a measles virus IgM assay; this assay also failed to provide any evidence of measles virus infection in the Crohn's disease group. Although the IgM ELISA for measles virus may have a poor predictive value in diagnosis of acute (or presumably reactivated) infection, with variation between different commercially available assays,'7 our corroboration of previously identified cases of acute measles and finding of overall similar results to the CFT analysis led us to believe that the assay was valid.
It is possible that a reduction in measles virus antibody titres reflects a generalised depression of host immunity in Crohn's disease. However, we found no such reduction in antibody titres to CMV, HSV, or adenovirus. Furthermore, analysis of other published literature does not suggest any evidence for reduced serum levels of antibodies to viral or bacterial pathogens in Crohn's disease. In contrast, raised levels of antibodies to bacterial pathogens have been found, a phenomenon that is thought to reflect translocation of bacteria across the mucosa of diseased bowel. '8 A potential shortcoming in our study is a lack of validated historical data for our subjects concerning any history of known or suspected previous measles virus infection. However, previous studies have suggested that a history of measles virus infection does not correlate with level of antibody titres, probably as a result of inaccurate recall or diagnosis."' Likewise, a history of measles immunisation is unreliable,20 and we therefore chose not to include these potentially confounding questions in our study.
In summary, our study does not support the hypothesis that measles virus is involved in the causation of Crohn's disease, according to currently accepted models of disease pathogenesis. However, the reduced measles virus antibody levels in patients with Crohn's disease compared with controls suggests the possibility of a specific host immune defect and deserves further study. Further information may be gained by studying a more extensive cohort, including newly diagnosed or untreated, or both, cases.
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